Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

DNA Ginkgo Bioworks Holdings, Inc.

Hardwoods, known as broadleafs, are trees classed as angiosperms with ovules enclosed for fruit protection. When appropriately watered on good fertile sites or fed in the landscape with a unique tree ...

Skills are folders of instructions, scripts, and resources that Claude loads dynamically to improve performance on specialized tasks. Skills teach Claude how to complete specific tasks in a repeatable ...